Physician profile
Eunice E Park
NPI 1962660530
$4,602.18
in general payments reported to CMS, 2019-2025
9 companies · $602 in 2025
The $602 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23.93 · 2021: $754 · 2022: $493 · 2023: $1,972 · 2024: $757 · 2025: $602.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,886 · Travel and Lodging: $445.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,886.32 |
| Travel and Lodging | $445.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $3,789.81 | 2021-2025 | Xeomin |
| Revance Therapeutics, INC. | $302.35 | 2024-2025 | Daxxify |
| Stryker Corporation | $190.16 | 2021 | |
| Intersect Ent, INC. | $146.06 | 2021 | |
| Solta Medical, A Division of Bausch Health US, LLC | $49.67 | 2025 | Clear & Brilliant |
| Galderma Laboratories, L.P. | $45.69 | 2022-2024 | |
| Ucb, INC. | $33.75 | 2022 | |
| Optinose US, INC. | $23.93 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $20.76 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eunice Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.